IPSEN Profile


Odds of Distress

Analyze Filter    Check how we calculate scores
Equity ratings for IPSEN are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 7, 2019 and ending today December 6, 2019. Click here to learn more.

IPSEN Profile

Ipsen S.A. operates as a biopharmaceutical company worldwide. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen Sa operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 5700 people. more
CEORichard PaulsonView All
Macroaxis Advice
InstrumentUSA OTC Stock View All
Business Address65, quai Georges Gorse
ExchangeBATS Exchange
IndustryDrug Manufacturers?Specialty & Generic
Phone33 1 58 33 50 00
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
IPSEN [IPSEF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mid-Cap' category with current market capitalization of 9.19 B. IPSEN classifies itself under Healthcare sector and is part of Drug Manufacturers?Specialty & Generic industry. The entity has 83.04 M outstanding shares. IPSEN PROMESSES has accumulated about 265.61 M in cash with 492.67 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22.
Check IPSEN Probability Of Bankruptcy

IPSEN Target Price Odds Analysis

Odds Below 113.75HorizonTargetOdds Above 113.75
42.99%30 days 113.75 56.86%
Based on normal probability distribution, the odds of IPSEN to move above current price in 30 days from now is about 56.86 (This IPSEN probability density function shows the probability of IPSEN OTC Stock to fall within a particular range of prices over 30 days) .

IPSEN Risk Profiles

IPSEN Key Fundamentals

IPSEN Against Markets

Did you try this?

Run Volatility Analysis Now


Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Module

IPSEN Corporate Directors

Herve Couffin Independent Director
Henri Beaufour Director
Helene AuriolPotier Director
Please also check Risk vs Return Analysis. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.
Search macroaxis.com